Publication | Closed Access
Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
259
Citations
17
References
2008
Year
Addition of sitagliptin 100 mg once daily to ongoing metformin therapy was well-tolerated and resulted in significant glycemic improvement in patients with moderately severe T2DM who were treated for 30 weeks.
| Year | Citations | |
|---|---|---|
Page 1
Page 1